Cargando…

Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review

Biologic drugs are therapeutic modalities designed to inhibit specific cytokine signaling pathways. The introduction of these drugs in the management of autoimmune diseases has dramatically changed the treatment paradigm of chronic systemic immune-mediated inflammatory disorders. However, despite th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammed, Reem Hamdy A, Essam, Mahmoud, Anwar, Ismail, Shehab, Hany, komy, Mohamed El
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Case Report and Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541761/ https://www.ncbi.nlm.nih.gov/pubmed/37773730 http://dx.doi.org/10.1177/03000605231200270

Ejemplares similares

Infliximab treatment–induced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction
por: Ishii-Osai, Yasue, et al.
Publicado: (2015)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
por: Xia, Ping, et al.
Publicado: (2021)

Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
por: Kołt-Kamińska, Marta, et al.
Publicado: (2021)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Psoriasis and staphylococcus aureus skin colonization in Moroccan patients
por: Elfatoiki, Fatima Zahra, et al.
Publicado: (2016)

Dramatic Response of Nail Psoriasis to Infliximab
por: Safa, Gilles, et al.
Publicado: (2011)

Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis
por: Barahimi, Mitra, et al.
Publicado: (2021)

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease
por: Agrawal, Gaurav, et al.
Publicado: (2015)

Two cases of Erythrodermic psoriasis treated with Golimumab
por: Kudsi, Mayssoun, et al.
Publicado: (2022)

Clinico-dermoscopic features of alopecia areata in patients with psoriasis
por: Tassone, Francesco, et al.
Publicado: (2018)

Use of risankizumab in two HIV-positive patients with psoriasis
por: Maliyar, Khalad, et al.
Publicado: (2023)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Méthotrexate et psoriasis: à propos de 46 cas
por: Inani, Kawtar, et al.
Publicado: (2014)

Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
por: Pai, Ganesh, et al.
Publicado: (2017)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
por: Anderko, Marian, et al.
Publicado: (2019)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)

New onset and exacerbation of psoriasis after COVID-19 vaccination
por: Wei, Nancy, et al.
Publicado: (2021)

Treatment Response of Patients with Erythrodermic Psoriasis after Switching to Guselkumab
por: Chiang, Cheng-Ying, et al.
Publicado: (2021)

Treatment of severe psoriasis with infliximab
por: Leman, JA, et al.
Publicado: (2008)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

A Case of Paradoxical Reactions to Biologic Therapy for Psoriasis
por: Zhou, Qianqian, et al.
Publicado: (2023)

Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review
por: Pinter, Andreas, et al.
Publicado: (2019)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021)

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
por: Pangilinan, Mary Catherine G., et al.
Publicado: (2020)

Successful treatment of juvenile generalized pustular psoriasis with infliximab therapy: two case reports
por: Lu, Jiajing, et al.
Publicado: (2020)

Psoriasis, Anti-Tumor Necrosis Factor Therapy, and Tuberculosis: Report of Three Challenging Cases and Literature Review
por: Solovan, Caius, et al.
Publicado: (2013)

Atopic Dermatitis as a Paradoxical Effect of Secukinumab for the Treatment of Psoriasis
por: Mendes Roncada, Eduardo V., et al.
Publicado: (2021)

IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis
por: Segawa, Yuka, et al.
Publicado: (2020)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
por: Suzuki, Taketo, et al.
Publicado: (2019)

Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
por: Pinter, Andreas, et al.
Publicado: (2018)

Clinical Characteristics of 18 Patients with Psoriasis and Multiple Myeloma Identified Through Digital Health Crowdsourcing
por: Jin, Joy Q., et al.
Publicado: (2020)

Palmoplantar pompholyx secondary to interleukin 17A inhibitor therapy for psoriasis: A case series
por: Peera, Melissa, et al.
Publicado: (2021)

Arthropathic psoriasis complicated by a paradoxical reaction in the form of erythrodermic psoriasis following adalimumab and by an allergic reaction following infliximab which was successfully managed with secukinumab
por: Tichy, Martin
Publicado: (2019)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
por: Udkoff, Jeremy, et al.
Publicado: (2016)

Case series of psoriasis associated with tumor necrosis factor-α inhibitors in children with chronic recurrent multifocal osteomyelitis
por: Campbell, Julie Ann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2ju3k0ira4m0c0iu9hgj3oo98n